Cold thinking on ten hot issues in the treatment of early breast cancer / 中华外科杂志
Chinese Journal of Surgery
;
(12): 213-218, 2022.
Artigo
em Chinês
| WPRIM
| ID: wpr-935602
ABSTRACT
With the development of new strategies like target therapy and immunotherapy, early breast cancer treatment has become more standardized, and the interval of disease free survival has been extended. Although guidelines and expert consensus have provided supports for clinical decision making, there are still some controversial issues in clinical practice, attributing to different treatment concepts, product indications and accessibility. These controversial issues would eventually affect the treatment of early breast cancer. This year in 2021, the approval of new indications of drugs like abemaciclib and the popularity of dual anti-human epidermal growth factor receptor 2 targeted drugs have promoted the change of treatment modalities for different types of early breast cancer. To this end, ten hot topics of early breast cancer are summarized according to their different molecular typing and treatment stages for discussion.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Neoplasias da Mama
/
Receptor ErbB-2
/
Intervalo Livre de Doença
Tipo de estudo:
Guia de Prática Clínica
/
Estudo prognóstico
/
Pesquisa qualitativa
Limite:
Feminino
/
Humanos
Idioma:
Chinês
Revista:
Chinese Journal of Surgery
Ano de publicação:
2022
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS